Patent · US Active

Pharmaceutical composition comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-quinazolinamine

US8586091B2 · kind B2 · utility

3Cited by

1References

10Claims

0Family size

Assignee

ratiopharm GmbH · DE

Inventors

Katrin Rimkus · Iserlohn, DE
Frank Muskulus · Gröbenzell, DE
Sandra Brueck · Borgo San Lazzaro, DE
Jana Paetz · Bonn, DE

Key dates

Filing date	Aug 24, 2009
Grant date	Nov 19, 2013
Priority date	—
Expiry date	Aug 24, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine as active pharmaceutical ingredient and a process of preparing such composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.